One of the worst things about osteosarcoma, which is awful for both dog and owner in every respect, is there have not been any new treatments for the disease in decades.
Until now. We have been following Dr. Nicola Mason’s work at the University of Pennsylvania on a new immunotherapy treatment for osteosarcoma patients, and now, finally, it has been granted a conditional license by the FDA and will be available around the country. Read more
An article co-written by SDCA Health and Genetics Chair John Dillberger, DVM PhD, has just been published in Canine Genetics and Epidemiology. Entitled “Osteosarcoma Inheritance in Two Families of Scottish Deerhounds,” you can read the entire article here, or here is the plain English summary: Read more
The Health & Genetics Committee is very excited to announce a new osteosarcoma project!
This project undertakes the very important task of seeing whether Deerhounds have any of the mutations found to date in two close relatives, the Greyhound and Irish Wolfhound, as well as Rottweilers, and lays the groundwork for future studies. Read more
Here is the slide presentation from the health seminar on osteosarcoma at the 2015 National Specialty. Our presenter was Dr. Marlene Hauck, who is an oncologist at North Carolina State University Veterinary School and who has been researching osteosarcoma in Deerhounds. Read more
Reprinted from the January/February 2014 Claymore.
While there haven’t been any earth-shattering discoveries this year, research into the health problems that affect Deerhounds has made some slow and steady progress on several fronts. There are also a couple of new projects. Read more
Interesting study coming out of Penn on pain management for dogs with osteo: